New acting director of #CBER, FDA insider #ScottSteele, promises continuity with PeterMarks on the non-vaccine side of biologics drug regulation.
Regulatory science and molecular biology background.
Regulatory science and molecular biology background.
April 2, 2025 at 6:00 AM
New acting director of #CBER, FDA insider #ScottSteele, promises continuity with PeterMarks on the non-vaccine side of biologics drug regulation.
Regulatory science and molecular biology background.
Regulatory science and molecular biology background.